Clinical activities not planned in BGRC: Baxter

Since 2011, Dr Marcus Schabacker has served as vice president of R&D for Baxter’s medical products business.


Dr Marcus Schabacker, vice president, R&D, medical products, Baxter International Inc

In this role, he is instrumental in aligning R&D and commercial opportunities to accelerate innovation at Baxter and enhance care for patients globally.

Dr Schabacker holds an MD and a Doctorate in anesthesia from Medical University of Lübeck in Germany, and certifications in anesthesiology, disaster medicine and emergency medicine.


Q: India has taken a beating in the area of clinical trials. Almost half of the clinical trials in India is halted. In such scenario, why do you think establishing a Baxter Global Research Center (BGRC) in India with Syngene would contribute to your R&D expansion strategy?

Dr Schabacker: Many R&D activities are required prior to the need for clinical trials, and Baxter's global research center in India is very focused on these R&D activities.

Previous 1 3 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email